Tumour Fas Ligand:Fas Ratio Greater Than 1 Is an Independent Marker of Relative Resistance to Tamoxifen Therapy in Hormone Receptor Positive Breast Cancer

Breast Cancer Research - United Kingdom
doi 10.1186/bcr456
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2018English

Low P27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy

Clinical Cancer Research
Cancer ResearchOncology
2009English

Sphingosine Kinase 1 Activation by Estrogen Receptor Α36 Contributes to Tamoxifen Resistance in Breast Cancer

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2018English

AKT1 - A New Marker for Tamoxifen Resistance in ER-Dependent Breast Cancer

2004English

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2003English

Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Progesterone Receptor Expression in Proliferating Cancer Cells of Hormone-Receptor-Positive Breast Cancer

Tumor Biology
MedicineCancer Research
2018English

Phosphorylation Independent eIF4E Translational Reprogramming of Selective mRNAs Determines Tamoxifen Resistance in Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy